 | • レポートコード：GIR201105684 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ナノ医薬品の世界市場を調査対象にし、ナノ医薬品の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション）、用途別分析（がん・腫瘍、自己免疫疾患、炎症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Merck、Eli Lilly、Abbott、Pfizer、Sanofi、Novartis、Johnson & Johnson、Roche、GlaxoSmithKline、Astrazeneca、OSI Pharmaceuticals、Mitsubishi Pharma、Celgene、Selecta Biosciences、Kadmon Pharmaceuticals、Gilead Sciences、Novavax、Kaken Pharmaceutical、Samyang Biopharm、Stryker、Par Pharmaceutical、Lummy、Cerulean Pharma、Navidea Biopharmaceuticals ・メーカー別販売量、売上、市場シェア ・ナノ医薬品の地域別市場分析 ・ナノ医薬品の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ナノ医薬品のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ナノ医薬品のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ナノ医薬品の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ナノ医薬品の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ナノ医薬品の種類別市場規模2015-2020：リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションとナノエマルション、ナノサスペンション ・ナノ医薬品の用途別市場規模2015-2020：がん・腫瘍、自己免疫疾患、炎症、その他 ・ナノ医薬品の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Nanopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Nanopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4%% in the forecast period of 2020 to 2025 and will expected to reach USD 39510 million by 2025, from USD 24720 million in 2019.
Market segmentation
Nanopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nanopharmaceuticals market has been segmented into
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
By Application, Nanopharmaceuticals has been segmented into:
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Nanopharmaceuticals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nanopharmaceuticals Market Share Analysis
Nanopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Nanopharmaceuticals are:
Merck
Eli Lilly
Abbott
Pfizer
Sanofi
Novartis
Johnson & Johnson
Roche
GlaxoSmithKline
Astrazeneca
OSI Pharmaceuticals
Mitsubishi Pharma
Celgene
Selecta Biosciences
Kadmon Pharmaceuticals
Gilead Sciences
Novavax
Kaken Pharmaceutical
Samyang Biopharm
Stryker
Par Pharmaceutical
Lummy
Cerulean Pharma
Navidea Biopharmaceuticals
Among other players domestic and global, Nanopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals in 2018 and 2019.
Chapter 3, the Nanopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nanopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nanopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Nanopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Overview of Global Nanopharmaceuticals Market
1.4.1 Global Nanopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Product and Services
2.6.4 Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Product and Services
2.7.4 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Product and Services
2.8.4 Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Product and Services
2.9.4 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astrazeneca
2.10.1 Astrazeneca Details
2.10.2 Astrazeneca Major Business
2.10.3 Astrazeneca Product and Services
2.10.4 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 OSI Pharmaceuticals
2.11.1 OSI Pharmaceuticals Details
2.11.2 OSI Pharmaceuticals Major Business
2.11.3 OSI Pharmaceuticals Product and Services
2.11.4 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mitsubishi Pharma
2.12.1 Mitsubishi Pharma Details
2.12.2 Mitsubishi Pharma Major Business
2.12.3 Mitsubishi Pharma Product and Services
2.12.4 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business
2.13.3 Celgene Product and Services
2.13.4 Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Selecta Biosciences
2.14.1 Selecta Biosciences Details
2.14.2 Selecta Biosciences Major Business
2.14.3 Selecta Biosciences Product and Services
2.14.4 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kadmon Pharmaceuticals
2.15.1 Kadmon Pharmaceuticals Details
2.15.2 Kadmon Pharmaceuticals Major Business
2.15.3 Kadmon Pharmaceuticals Product and Services
2.15.4 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gilead Sciences
2.16.1 Gilead Sciences Details
2.16.2 Gilead Sciences Major Business
2.16.3 Gilead Sciences Product and Services
2.16.4 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Novavax
2.17.1 Novavax Details
2.17.2 Novavax Major Business
2.17.3 Novavax Product and Services
2.17.4 Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Kaken Pharmaceutical
2.18.1 Kaken Pharmaceutical Details
2.18.2 Kaken Pharmaceutical Major Business
2.18.3 Kaken Pharmaceutical Product and Services
2.18.4 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Samyang Biopharm
2.19.1 Samyang Biopharm Details
2.19.2 Samyang Biopharm Major Business
2.19.3 Samyang Biopharm Product and Services
2.19.4 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Stryker
2.20.1 Stryker Details
2.20.2 Stryker Major Business
2.20.3 Stryker Product and Services
2.20.4 Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Par Pharmaceutical
2.21.1 Par Pharmaceutical Details
2.21.2 Par Pharmaceutical Major Business
2.21.3 Par Pharmaceutical Product and Services
2.21.4 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Lummy
2.22.1 Lummy Details
2.22.2 Lummy Major Business
2.22.3 Lummy Product and Services
2.22.4 Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Cerulean Pharma
2.23.1 Cerulean Pharma Details
2.23.2 Cerulean Pharma Major Business
2.23.3 Cerulean Pharma Product and Services
2.23.4 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Navidea Biopharmaceuticals
2.24.1 Navidea Biopharmaceuticals Details
2.24.2 Navidea Biopharmaceuticals Major Business
2.24.3 Navidea Biopharmaceuticals Product and Services
2.24.4 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nanopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nanopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Nanopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nanopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nanopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nanopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nanopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nanopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nanopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nanopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nanopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nanopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nanopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nanopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Nanopharmaceuticals Price by Type (2015-2020)
11 Global Nanopharmaceuticals Market Segment by Application
11.1 Global Nanopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Nanopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Nanopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nanopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Nanopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Nanopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Nanopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nanopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Nanopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nanopharmaceuticals Market Forecast (2021-2025)
12.3 Nanopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Nanopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Nanopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Nanopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Nanopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Nanopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nanopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanopharmaceuticals Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Nanopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Nanopharmaceuticals Major Business
Table 10. Merck Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 11. Merck SWOT Analysis
Table 12. Merck Nanopharmaceuticals Product and Services
Table 13. Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 15. Eli Lilly Nanopharmaceuticals Major Business
Table 16. Eli Lilly Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 17. Eli Lilly SWOT Analysis
Table 18. Eli Lilly Nanopharmaceuticals Product and Services
Table 19. Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Abbott Basic Information, Manufacturing Base and Competitors
Table 21. Abbott Nanopharmaceuticals Major Business
Table 22. Abbott Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 23. Abbott SWOT Analysis
Table 24. Abbott Nanopharmaceuticals Product and Services
Table 25. Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer Nanopharmaceuticals Major Business
Table 28. Pfizer Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer SWOT Analysis
Table 30. Pfizer Nanopharmaceuticals Product and Services
Table 31. Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Sanofi Basic Information, Manufacturing Base and Competitors
Table 33. Sanofi Nanopharmaceuticals Major Business
Table 34. Sanofi Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 35. Sanofi SWOT Analysis
Table 36. Sanofi Nanopharmaceuticals Product and Services
Table 37. Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Nanopharmaceuticals Major Business
Table 40. Novartis Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 41. Novartis SWOT Analysis
Table 42. Novartis Nanopharmaceuticals Product and Services
Table 43. Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 45. Johnson & Johnson Nanopharmaceuticals Major Business
Table 46. Johnson & Johnson Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 47. Johnson & Johnson SWOT Analysis
Table 48. Johnson & Johnson Nanopharmaceuticals Product and Services
Table 49. Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Roche Basic Information, Manufacturing Base and Competitors
Table 51. Roche Nanopharmaceuticals Major Business
Table 52. Roche Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 53. Roche SWOT Analysis
Table 54. Roche Nanopharmaceuticals Product and Services
Table 55. Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 57. GlaxoSmithKline Nanopharmaceuticals Major Business
Table 58. GlaxoSmithKline Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 59. GlaxoSmithKline SWOT Analysis
Table 60. GlaxoSmithKline Nanopharmaceuticals Product and Services
Table 61. GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 63. Astrazeneca Nanopharmaceuticals Major Business
Table 64. Astrazeneca Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 65. Astrazeneca SWOT Analysis
Table 66. Astrazeneca Nanopharmaceuticals Product and Services
Table 67. Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. OSI Pharmaceuticals Nanopharmaceuticals Major Business
Table 70. OSI Pharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 71. OSI Pharmaceuticals SWOT Analysis
Table 72. OSI Pharmaceuticals Nanopharmaceuticals Product and Services
Table 73. OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table 75. Mitsubishi Pharma Nanopharmaceuticals Major Business
Table 76. Mitsubishi Pharma Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 77. Mitsubishi Pharma SWOT Analysis
Table 78. Mitsubishi Pharma Nanopharmaceuticals Product and Services
Table 79. Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Celgene Basic Information, Manufacturing Base and Competitors
Table 81. Celgene Nanopharmaceuticals Major Business
Table 82. Celgene Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 83. Celgene SWOT Analysis
Table 84. Celgene Nanopharmaceuticals Product and Services
Table 85. Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table 87. Selecta Biosciences Nanopharmaceuticals Major Business
Table 88. Selecta Biosciences Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 89. Selecta Biosciences SWOT Analysis
Table 90. Selecta Biosciences Nanopharmaceuticals Product and Services
Table 91. Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 93. Kadmon Pharmaceuticals Nanopharmaceuticals Major Business
Table 94. Kadmon Pharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 95. Kadmon Pharmaceuticals SWOT Analysis
Table 96. Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services
Table 97. Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 99. Gilead Sciences Nanopharmaceuticals Major Business
Table 100. Gilead Sciences Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 101. Gilead Sciences SWOT Analysis
Table 102. Gilead Sciences Nanopharmaceuticals Product and Services
Table 103. Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Novavax Basic Information, Manufacturing Base and Competitors
Table 105. Novavax Nanopharmaceuticals Major Business
Table 106. Novavax Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 107. Novavax SWOT Analysis
Table 108. Novavax Nanopharmaceuticals Product and Services
Table 109. Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Kaken Pharmaceutical Nanopharmaceuticals Type and Application
Table 111. Kaken Pharmaceutical Nanopharmaceuticals Major Business
Table 112. Kaken Pharmaceutical Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 113. Kaken Pharmaceutical SWOT Analysis
Table 114. Kaken Pharmaceutical Nanopharmaceuticals Product and Services
Table 115. Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table 117. Samyang Biopharm Nanopharmaceuticals Major Business
Table 118. Samyang Biopharm Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 119. Samyang Biopharm SWOT Analysis
Table 120. Samyang Biopharm Nanopharmaceuticals Product and Services
Table 121. Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Stryker Basic Information, Manufacturing Base and Competitors
Table 123. Stryker Nanopharmaceuticals Major Business
Table 124. Stryker Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 125. Stryker SWOT Analysis
Table 126. Stryker Nanopharmaceuticals Product and Services
Table 127. Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 128. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 129. Par Pharmaceutical Nanopharmaceuticals Major Business
Table 130. Par Pharmaceutical Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 131. Par Pharmaceutical SWOT Analysis
Table 132. Par Pharmaceutical Nanopharmaceuticals Product and Services
Table 133. Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 134. Lummy Basic Information, Manufacturing Base and Competitors
Table 135. Lummy Nanopharmaceuticals Major Business
Table 136. Lummy Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 137. Lummy SWOT Analysis
Table 138. Lummy Nanopharmaceuticals Product and Services
Table 139. Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 140. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table 141. Cerulean Pharma Nanopharmaceuticals Major Business
Table 142. Cerulean Pharma Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 143. Cerulean Pharma SWOT Analysis
Table 144. Cerulean Pharma Nanopharmaceuticals Product and Services
Table 145. Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 146. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 147. Navidea Biopharmaceuticals Nanopharmaceuticals Major Business
Table 148. Navidea Biopharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 149. Navidea Biopharmaceuticals SWOT Analysis
Table 150. Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services
Table 151. Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 152. Global Nanopharmaceuticals Sales by Manufacturer (2018-2019) (K MT)
Table 153. Global Nanopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 154. Global Nanopharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 155. Global Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 156. Global Nanopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 157. North America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 158. North America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 159. North America Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 160. North America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 161. Europe Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 162. Europe Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 163. Europe Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 164. Asia-Pacific Nanopharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 165. Asia-Pacific Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 166. Asia-Pacific Nanopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 167. South America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 168. South America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 169. South America Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 170. South America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 171. Middle East & Africa Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 172. Middle East & Africa Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 173. Middle East & Africa Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 174. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 175. Global Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 176. Global Nanopharmaceuticals Sales Share by Type (2015-2020)
Table 177. Global Nanopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 178. Global Nanopharmaceuticals Revenue Share by Type (2015-2020)
Table 179. Global Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 180. Global Nanopharmaceuticals Sales Share by Application (2015-2020)
Table 181. Global Nanopharmaceuticals Sales Forecast by Regions (2021-2025) (K MT)
Table 182. Global Nanopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 183. Global Nanopharmaceuticals Sales Forecast by Type (2021-2025) (K MT)
Table 184. Global Nanopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 185. Global Nanopharmaceuticals Sales Forecast by Application (2021-2025)
Table 186. Global Nanopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 187. Direct Channel Pros & Cons
Table 188. Indirect Channel Pros & Cons
Table 189. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nanopharmaceuticals Picture
Figure 2. Global Sales Market Share of Nanopharmaceuticals by Type in 2019
Figure 3. Liposomes Picture
Figure 4. Polymeric Micelles Picture
Figure 5. Solid Lipid Nanoparticles Picture
Figure 6. Microemulsion and Nnanoemulsion Picture
Figure 7. Nanosuspension Picture
Figure 8. Nanopharmaceuticals Sales Market Share by Application in 2019
Figure 9. Cancer and Tumor Picture
Figure 10. Autoimmune Disorders Picture
Figure 11. Inflammation Picture
Figure 12. Others Picture
Figure 13. Global Nanopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Nanopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 34. Global Nanopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Nanopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 41. Global Nanopharmaceuticals Revenue Market Share by Regions in 2018
Figure 42. North America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. Europe Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 45. South America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 47. North America Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 49. North America Nanopharmaceuticals Sales Market Share by Countries in 2018
Figure 50. North America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Nanopharmaceuticals Revenue Market Share by Countries in 2018
Figure 52. United States Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 58. Germany Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Nanopharmaceuticals Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Nanopharmaceuticals Revenue Market Share by Regions 2019
Figure 66. China Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Nanopharmaceuticals Sales Market Share by Countries in 2019
Figure 73. South America Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 74. Brazil Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Nanopharmaceuticals Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Nanopharmaceuticals Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Nanopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
循環腫瘍細胞（CTC）及び癌幹細胞（CSC）の世界市場 2020年 Market Overview The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mar…- 高分子ホスホネートの世界市場 2020年 Market Overview The global Polymeric Phosphonates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polymeric Phosphonates…
- 腫瘍バイオマーカー検査の世界市場 2020年 Market Overview The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Biomarker Test mar…
- 腫瘍栄養の世界市場 2020年 Market Overview The global Tumor Nutrition market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Nutrition market report…
- ウィルムス腫瘍タンパク質の世界市場 2020年 Market Overview The global Wilms Tumor Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wilms Tumor Protein marke…